FARN:LON
Faron Pharmaceuticals Oy
GBX 42.55
arrow_upward
+2.53%(+1.05) 1రో
1 మే, 4:30:00 PM GMT+1 · GBX
search
అన్ని చిహ్నాలు
1రో
5రో
1నె
6నె
YTD
1సం
5సం
గరి
| చిహ్నం | ధర | మార్చు | % మార్చు |
|---|
insights_autoFARNకు సంబంధించి టాప్ గణాంకాలు జెనరేట్ అవుతున్నాయి...
తెరువు
GBX 42.56
అధికం
GBX 42.56
తక్కువ
GBX 40.00
మార్కెట్ క్యాపిటలైజేషన్
౮౨.౮౦మి
సగటు వాల్యూమ్
౧౧౯.౧౭వే
వాల్యూమ్
౭.౦౩వే
52 వారాల గరిష్ఠం
GBX 261.17
52 వారాల కనిష్ఠం
GBX 38.00
EPS
-GBX 0.19
అవుట్స్టాండింగ్ షేర్లు
౩౧.౦౩మి
ఉద్యోగుల సంఖ్య
౩౩
వార్తల కథనాలు
వెబ్ అంతటా ఉండే సోర్స్ల నుండి
Simply Wall Street
·
1 గంట క్రితం
Rothschild Redburn Buy Rating Backs Credo Shift To Optics At High P/E
The Brown and White
·
1 గంట క్రితం
Former NYSE President Stacey Cunningham to deliver commencement speech
Investor's Business Daily
·
3 గంటల క్రితం
Dow Jones Futures: Stock Market Hits High After Bullish Pause; Apple, Broadcom In Buy Zones
MSN
·
3 గంటల క్రితం
Americans face decision on real estate vs. S&P 500 in 2026
ప్రొఫైల్
Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland.
The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the development of treatments for acute organ traumas, vascular damage and cancer immunotherapy.
Its lead product Traumakine has been developed to treat acute respiratory distress syndrome. It is currently undergoing international phase III clinical trials after an open-label, early-phase trial showed promising results in the treatment patients with ARDS. The drug is known to function by enhancing lung CD73 expression and increasing production of anti-inflammatory adenosine, such that vascular leaking and escalation of inflammation are reduced. The U.S. Food and Drug Administration FDA has accepted the proposed protocol design for the next Traumakine study in March 2020. The phase III study is a comparison of efficacy in the treatment of patients with ARDS.
In 2020 Traumakine was selected to take part in the WHO Solidarity trial and REMAP-CAP trials to find drugs for the symptoms of Covid_19. Wikipedia
Faron Pharmaceuticals Oy గురించిన వివరాలు
AI కంటెంట్లో తప్పులు ఉండవచ్చు. మరింత తెలుసుకోండి